Skip to main content
Log in

Biological therapy prioritisation decreases costs of AS

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2012 euros

Reference

  • Borras-Blasco J, et al. Dealing with the high cost of biological therapies: developing and implementing a biological therapy prioritization protocol for ankylosing spondylitis patients in a tertiary hospital. International Journal of Clinical Pharmacology and Therapeutics : 28 Sep 2015. Available from: URL: http://doi.org/10.5414/CP202410

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Biological therapy prioritisation decreases costs of AS. PharmacoEcon Outcomes News 739, 11 (2015). https://doi.org/10.1007/s40274-015-2529-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2529-4

Navigation